'Contactless' COVID-19 Trial to Test Common Anti-Inflammatory Drug: University of California San Francisco
April 18, 2020
April 18, 2020
SAN FRANCISCO, California, April 18 -- The University of California San Francisco campus issued the following news release:
UC San Francisco is recruiting newly diagnosed COVID-19 patients for a large global clinical trial testing whether the common anti-inflammatory drug colchicine can reduce hospitalization and death caused by the illness.
Using an innovative new "contactless" approach, researchers will ship the study drug directly to patients' homes wi . . .
UC San Francisco is recruiting newly diagnosed COVID-19 patients for a large global clinical trial testing whether the common anti-inflammatory drug colchicine can reduce hospitalization and death caused by the illness.
Using an innovative new "contactless" approach, researchers will ship the study drug directly to patients' homes wi . . .